{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:43:58Z","timestamp":1793835838685,"version":"4.6.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.035","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T10:35:44Z","timestamp":1321958144000},"page":"974-982","source":"Crossref","is-referenced-by-count":49,"title":["Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose"],"prefix":"10.1016","volume":"30","author":[{"given":"Scott A.","family":"Halperin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Scheifele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Noya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Meekison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zickler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Larriv\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Langley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly A.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Dobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Jordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.11.035_bib0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0010","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/01.inf.0000166163.02135.8b","article-title":"Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States","volume":"24","author":"Halperin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.vaccine.2010.12.010","article-title":"The global pertussis initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11\u201312 January 2010","volume":"29","author":"Guiso","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1086\/653938","article-title":"Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis","volume":"51","author":"Wei","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0025","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.vaccine.2007.09.031","article-title":"Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"25","author":"Barreto","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1503\/cmaj.050379","article-title":"Changing epidemiology and emerging risk groups for pertussis","volume":"174","author":"Galanis","year":"2006","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3122\/jabfm.19.6.603","article-title":"Pertussis infection in the United States: role for vaccination of adolescents and adults","volume":"19","author":"Brooks","year":"2006","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/655825","article-title":"Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults","volume":"51","author":"Mertsola","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0045","first-page":"145","article-title":"Pertussis notifications in Australia, 1991 to 1997","volume":"21","author":"Andrews","year":"1997","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0050","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1016\/j.vaccine.2010.05.070","article-title":"Investigation on a pertussis outbreak in a military school: risk factors and approach to vaccine efficacy","volume":"28","author":"Berger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0055","first-page":"283","article-title":"A pertussis outbreak among daycare children in Northern Israel: who gets sick?","volume":"12","author":"Hochwald","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/occmed\/kqq051","article-title":"Outbreak of Bordetella pertussis among oncology nurse specialists","volume":"60","author":"Baugh","year":"2010","journal-title":"Occup Med"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/INF.0b013e318197fac1","article-title":"Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children","volume":"28","author":"Waters","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0070","first-page":"796","article-title":"Use of mass Tdap vaccination to control an outbreak of pertussis in a high school\u2014Cook County, Illinois, September 2006\u2013January 2007","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0075","doi-asserted-by":"crossref","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","article-title":"Seroprevalance of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis","volume":"5","author":"de Greeff","year":"2010","journal-title":"PLoS ONE"},{"issue":"ACS-5,6","key":"10.1016\/j.vaccine.2011.11.035_bib0080","first-page":"1","article-title":"Prevention of pertussis in adolescents and adults","volume":"29","author":"National Advisory Committee on Immunization (NACI)","year":"2003","journal-title":"Can Commun Dis Rep"},{"issue":"RR3","key":"10.1016\/j.vaccine.2011.11.035_bib0085","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"RR17","key":"10.1016\/j.vaccine.2011.11.035_bib0090","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0095","unstructured":"Calendrier vaccinal d\u00e9taill\u00e9 2008. Nouvelles recommandations. Vaccination contre la coqueluche. http:\/\/www.sante.gouv.fr\/IMG\/pdf\/Calendrier_vaccinal_2008_-_nouvelles_recommandations.pdf [accessed 02.10.11]."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0100","unstructured":"Impfkalender. Epidemiologisches bulletin nr. 30. Robert Koch-Institut. http:\/\/www.rki.de\/cln_100\/nn_195844\/DE\/Content\/Infekt\/Impfen\/STIKO\/Empfehlungen\/Aktuelles\/Impfkalender,templateId=raw,property=publicationFile.pdf\/Impfkalender.pdf [accessed 02.10.11]."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0265","unstructured":"Australian immunisation handbook, 9th ed. Pertussis. Australian Government Department of Health and Ageing, 2008. p. 227-39."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0110","unstructured":"Minist\u00e8re de la Sant\u00e9 [Ministry of Health]. Calendrier vaccinal recommand\u00e9 au Luxembourg [Recommended immunization schedule in Luxembourg]. Portail Sant\u00e9 [Health Portal] [Internet]. Luxembourg: Minist\u00e8re de la Sant\u00e9 [Ministry of Health]. Available from: http:\/\/www.sante.public.lu\/fr\/rester-bonne-sante\/120-vaccinations\/calendrier-vaccinal\/index.html, 2011 Mar 18 [updated 18.03.11; cited 21.04.11]."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0115","unstructured":"Impfausschuss [Vaccine Committee]. Impfplan 2011 \u00d6sterreich: Evidenz-basierte Empfehlungen des Obersten Sanit\u00e4tsrates [Vaccination schedule in 2011 Austria: evidence-based recommendations of the National Health Council] [Internet]. Austria: Bundesministerium f\u00fcr Gesundheit [Federal Ministry of Health]. 38 p. Available from: http:\/\/www.bmg.gv.at\/cms\/home\/attachments\/7\/3\/0\/CH1081\/CMS1286449898381\/impfplan_2011.pdf, 2010 Oct 12 [cited 21.04.11] [in German]."},{"issue":"3 Suppl","key":"10.1016\/j.vaccine.2011.11.035_bib0120","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1590\/S0021-75572006000400003","article-title":"Acellular pertussis vaccine for adolescents","volume":"82","author":"de Carvalho","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0125","first-page":"635","article-title":"Indian Academy of Pediatrics Committee on Immunization (IAPCOI). Consensus recommendations on immunization, 2008","volume":"45","author":"Singhal","year":"2008","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0130","unstructured":"World Health Organization (WHO). Regional consultation to standardize EPI schedule in the Eastern Mediterranean Region of the World Health Organization (WHO EMRO). Cairo, Egypt: VPI\/EMRO; 2006. 23 p. Available from: http:\/\/www.who.int\/immunization\/sage\/3_EMRO_1_EPI_Schedule_Report.pdf, 2008 Mar 20 [cited 18.03.11]."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.vaccine.2010.10.025","article-title":"A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix\u2122) is immunogenic and well tolerated in adults","volume":"29","author":"Booy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0140","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/514338","article-title":"Immunity to pertussis 5 years after booster immunization during adolescence","volume":"44","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5 Suppl","key":"10.1016\/j.vaccine.2011.11.035_bib0145","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1097\/01.inf.0000160914.59160.41","article-title":"Duration of immunity against pertussis after natural infection or vaccination","volume":"24","author":"Wendelboe","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/421943","article-title":"Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine","volume":"39","author":"Edelman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.296.6622.612","article-title":"Duration of effectiveness of pertussis vaccine: Evidence from a 10 year community study","volume":"296","author":"Jenkinson","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0160","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.vaccine.2008.04.089","article-title":"Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data","volume":"26","author":"Bailleux","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0165","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2005.06.009","article-title":"Pertussis antitoxin decay after vaccination with DTPa response to a first booster dose 3 \u00bd-6 \u00bd years after the third vaccine dose","volume":"23","author":"Hallander","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4161\/hv.5.5.6911","article-title":"Safety of Tdap-IPV given one month after TD-IPV booster in healthy young adults","volume":"5","author":"Beytout","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.inf.0000202082.56403.c4","article-title":"How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus\u2013diphtheria\u2013acellular pertussis vaccine?","volume":"25","author":"Halperin","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0180","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1016\/j.vaccine.2010.09.034","article-title":"The safety of immunizing with tetanus\u2013diphtheria\u2013acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak","volume":"28","author":"Talbot","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0185","first-page":"117","article-title":"Enhanced surveillance for vaccine-associated adverse events: dTap catch-up of high school students in Yukon","volume":"31","author":"David","year":"2005","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0190","unstructured":"National Advisory Committee on Immunization (NACI). Interval between administration of vaccines against diphtheria, tetanus, and pertussis. Can Commun Dis Rep 2005;31(ACS-8 and 9):17\u201322."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0195","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00006454-200004000-00003","article-title":"Adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults","volume":"19","author":"Halperin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0200","unstructured":"Sanofi Pasteur. Adacel\u00ae [product monograph] [Internet]. Toronto (ON): Sanofi Pasteur; 2009, August. p. 1\u201351. Available from: https:\/\/www.vaccineshoppecanada.com\/secure\/pdfs\/ca\/ADACEL_E.pdf."},{"key":"10.1016\/j.vaccine.2011.11.035_bib0270","doi-asserted-by":"crossref","first-page":"8459","DOI":"10.1016\/j.vaccine.2011.07.068","article-title":"Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4-5 years after a previous dose","volume":"29","author":"Halperin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4161\/hv.6.7.11760","article-title":"Repeated administration of a reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix (IPV)","volume":"6","author":"Knuf","year":"2010","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0215","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1542\/peds.108.5.e81","article-title":"Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience","volume":"108","author":"Salmaso","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00431-001-0893-5","article-title":"Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine","volume":"161","author":"Lugauer","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0225","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0230","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A Search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of an acellular pertussis vaccine among adolescents and adults","volume":"353","author":"Ward","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/INF.0b013e318199d2fc","volume":"28","author":"Greenberg","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0245","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","article-title":"Pertussis of adults and infants","volume":"2","author":"Wirsing von K\u00f6nig","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0250","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0264-410X(01)00393-0","article-title":"Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration","volume":"20","author":"Campins-Mart\u00ed","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0255","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1016\/j.vaccine.2006.12.017","article-title":"Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting","volume":"25","author":"Forsyth","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.035_bib0260","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00063030-200620060-00008","article-title":"Reduced-antigen, combined diphtheria, tetanus, and acellular pertussis vaccine (Boostrix\u2122). A review of its use as a single-dose booster immunization","volume":"20","author":"Frampton","year":"2006","journal-title":"BioDrugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11018202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T04:20:21Z","timestamp":1543378821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11018202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11018202"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}